Align Technology, Inc.
NASDAQ:ALGNMedical - Devices
-$5.99 today
- Market cap
- $11.56B
- Beta
- 1.67
- P/E (TTM)
- 28.8
- EPS (TTM)
- $6.02
Volume 0.89M
Average 1.05M
ALGN Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Align Technology, Inc.NASDAQ: ALGN
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue growth accelerates
Q2 FY2026 cost of revenue of $368.19M rose 21.0% year over year, ahead of the +15.8% change in trailing-twelve-month cost of revenue. Sequentially, it rose 21.3% from the prior quarter. Over 3 fiscal years it compounded at +5.1% a year.
Context
- Cost of revenue amounted to 31.7% of revenue in FY2025, up 1.7 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +21.0% holds above the trailing-twelve-month pace of +15.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.28B USD
- Year-over-year change
- +6.5%
- 4-year CAGR
- +5.9%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.28B | +6.5% |
| FY2024 | 2024-12-31 | 1.2B | +3.8% |
| FY2023 | 2023-12-31 | 1.16B | +5.0% |
| FY2022 | 2022-12-31 | 1.1B | +8.2% |
| FY2021 | 2021-12-31 | 1.02B | — |
Cost of Revenue vs competitors
How ALGN compares with its peers on the latest reported figures
- ALGN's LTM Jun 2026 cost of revenue of $1.39B is the 2nd highest of the 3 companies compared; the peer median is $1.57B.
- Its year-over-year change of +15.8% is the highest of 3, against a peer median of +6.5%.
- Cost of revenue amounts to 33.5% of revenue for ALGN, versus a peer median of 47.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.88B | +4.4% | +0.8% | 51.1% | |
| LTM Jun 2026 | $1.39B | +15.8% | +5.1% | 33.5% | |
| LTM Oct 2026 | $1.27B | +8.6% | +4.2% | 44.0% | |
| Peer median (excluding ALGN) | $1.57B | +6.5% | +2.5% | 47.6% | |
Competitors are the stored peer set for ALGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.95B | 3.73B | 3.86B | 4B | 4.03B |
| Cost of Revenue | 1.02B | 1.1B | 1.16B | 1.2B | 1.28B |
| Gross Profit | 2.94B | 2.63B | 2.71B | 2.8B | 2.76B |
| Gross Margin | 74.3% | 70.5% | 70.1% | 70.0% | 68.3% |
| Research & Development | 250.32M | 305.26M | 346.83M | 364.2M | 369.91M |
| Selling, General & Admin | 1.71B | 1.67B | 1.7B | 1.76B | 1.76B |
| Operating Expenses | 1.96B | 1.99B | 2.06B | 2.19B | 2.14B |
| Depreciation & Amortization | 108.73M | 125.79M | 142.4M | 145.03M | 237.44M |
| EBITDA | 1.12B | 779.84M | 799.06M | 816.8M | 822.72M |
| EBITDA Margin | 28.4% | 20.9% | 20.7% | 20.4% | 20.4% |
| Operating Income | 976.4M | 642.6M | 643.34M | 607.63M | 616.22M |
| Operating Margin | 24.7% | 17.2% | 16.7% | 15.2% | 15.3% |
| Interest Income | 3.1M | 5.37M | 17.26M | 20.22M | 16.05M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 36.02M | (43.54M) | (2.13M) | 1.33M | (30.93M) |
| Income Before Tax | 1.01B | 599.06M | 641.2M | 608.96M | 585.29M |
| Pre-Tax Margin | 25.6% | 16.0% | 16.6% | 15.2% | 14.5% |
| Income Tax Expense | 240.4M | 237.48M | 196.15M | 187.6M | 174.94M |
| Net Income | 772.02M | 361.57M | 445.05M | 421.36M | 410.35M |
| Net Margin | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
| EPS (Basic) | 9.78 | 4.62 | 5.82 | 5.63 | 5.66 |
| EPS (Diluted) | 9.69 | 4.61 | 5.81 | 5.62 | 5.65 |
| Weighted Avg Shares | 78.92M | 78.19M | 76.43M | 74.88M | 72.54M |
| Weighted Avg Shares (Diluted) | 79.67M | 78.42M | 76.57M | 74.99M | 72.59M |
Align Technology, Inc.
NASDAQ:ALGN
Intrinsic Alpha fair value
Locked
Current Price
$163.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.